EQUUS TOTAL RETURN, INC. EQS
and all of the assets and liabilities of the Partnership were transferred to the Fund in exchange for shares of common stock of the Fund.
On August 11, 2006, our shareholders approved the change of the Fund's investment strategy to a total return investment objective.
This strategy seeks to provide the highest total return, consisting of capital appreciation and current income. In connection with this
strategic investment change, the shareholders also approved the change of name from Equus II Incorporated to Equus Total Return, Inc.
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | — | — | $225.0K | $0 | $0 | $291.0K | — |
| SG&A | $191.0K | $189.0K | $133.0K | $130.0K | $140.0K | $168.0K | — |
| Total operating expenses | $5.1M | $4.6M | $4.3M | $3.6M | $3.5M | $5.2M | — |
| Interest expense | $683.0K | $138.0K | $25.0K | $4.0K | $3.0K | $27.0K | — |
| Pre-tax income | -$14.1M | -$18.7M | $13.0M | -$1.1M | $2.6M | -$12.3M | — |
| Income tax | $24.0K | $36.0K | $13.0K | $15.0K | $25.0K | $22.0K | — |
| Net income | -$14.2M | -$18.8M | $12.9M | -$1.1M | $2.6M | -$12.3M | — |
| EPS, basic | -1.03 | -1.38 | 0.96 | 0.08 | — | — | — |
| EPS, diluted | -1.03 | -1.38 | 0.96 | -0.08 | 0.19 | -0.91 | — |
| Shares, diluted (wtd. avg.) | $13.7M | $13.6M | $13.5M | $13.5M | $13.5M | $13.5M | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | $133.0K | $262.0K | $6.5M | $19.3M | $23.5M | $23.6M | $4.3M |
| Short-term investments | — | — | — | $6.0M | $2.5M | — | — |
| Total assets | $21.3M | $29.9M | $93.5M | $41.7M | $39.7M | — | — |
| Accounts payable | $414.0K | $332.0K | $172.0K | $107.0K | $46.0K | — | — |
| Total liabilities | $4.8M | $426.0K | $45.3M | $6.4M | $3.4M | — | — |
| Retained earnings | $59.5M | $45.3M | -$26.5M | -$39.5M | -$38.3M | — | — |
| Total equity | $16.6M | $29.5M | $48.3M | $35.2M | $36.4M | $33.8M | $46.0M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -$2.1M | $38.2M | -$51.4M | -$7.7M | $21.1M | $24.6M | — |
| Stock-based compensation | $270.0K | $0 | $0 | $0 | $0 | $80.0K | — |
| Financing cash flow | $2.0M | -$45.0M | $39.1M | $3.5M | -$21.5M | -$5.0M | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001096906-26-000571.